文献速递神经肿瘤

松果体区肿瘤立体定向放射外科治疗后的组织学分层肿瘤控制与患者生存:国际伽玛刀研究基金会报告

Histology-Stratified Tumor Control and Patient Survival After Stereotactic Radiosurgery for Pineal Region Tumors: A Report From the International Gamma Knife Research Foundation.
PubMed 文献 · World Neurosurg · 2017-07-24

这项多中心回顾性研究评估了70例松果体区肿瘤患者接受立体定向放射外科(SRS)后的组织学分层结局。中位随访47个月,不同组织学类型的局部控制率和生存率差异显著,SRS被认为是安全的治疗方式,其具体作用高度依赖于肿瘤组织学。

要点

  • 松果体细胞瘤20年局部控制率和生存率分别为81%和76%。
  • 松果体母细胞瘤5年局部控制率和生存率分别为27%和48%。
  • 新发局灶性神经功能缺损、Parinaud综合征和脑积水的发生率分别为9%、7%和3%。

核心结论

  • SRS是松果体区肿瘤管理的安全方式,其具体作用高度依赖于肿瘤组织学,应尽力获得可靠的组织学诊断。

研究设计与样本

  • 回顾性评估5个中心接受SRS治疗且影像随访至少6个月的松果体区肿瘤患者,收集病历数据并进行组织学水平分析,包括 actuarial 肿瘤控制和生存分析。

主要发现

  • 1989年至2014年间共治疗70例患者,中位随访47个月。
  • 诊断构成:松果体细胞瘤37%、松果体母细胞瘤19%、中间分化松果体实质肿瘤10%、松果体区乳头状肿瘤9%、生殖细胞瘤7%、畸胎瘤3%、胚胎性癌1%、未知14%。
  • 中位处方剂量为15 Gy,等剂量线为50%。
  • 松果体细胞瘤20年局部控制率和生存率分别为81%和76%;中间分化松果体实质肿瘤5年分别为50%和56%;松果体母细胞瘤5年分别为27%和48%;松果体区乳头状肿瘤5年分别为33%和100%;生殖细胞瘤20年分别为80%和80%;未知组织学肿瘤5年分别为61%和67%。
  • 新发局灶性神经功能缺损、Parinaud综合征和脑积水分别发生于9%、7%和3%的病例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pineal region tumors represent a rare and histologically diverse group of lesions. Few studies are available to guide management and the outcomes after stereotactic radiosurgery (SRS). METHODS: Patients who underwent SRS for a pineal region tumor and for whom at least 6 months of imaging follow-up was available were retrospectively assessed in 5 centers. Data were collected from the medical record and histology level analyses were performed, including actuarial tumor control and survival analyses. RESULTS: A total of 70 patients were treated between 1989 and 2014 with a median follow-up of 47 months. Diagnoses were pineocytoma (37%), pineoblastoma (19%), pineal parenchymal tumor of intermediate differentiation (10%), papillary tumor of the pineal region (9%), germinoma (7%), teratoma (3%), embryonal carcinoma (1%), and unknown (14%). Median prescription dose was 15 Gy at the 50% isodose line. Actuarial local control and survival rates were 81% and 76% at 20 years for pineocytoma, 50% and 56% at 5 years for pineal parenchymal tumor of intermediate differentiation, 27% and 48% at 5 years for pineoblastoma, 33% and 100% at 5 years for papillary tumor of the pineal region, 80% and 80% at 20 years for germinoma, and 61% and 67% at 5 years for tumors of unknown histology. New focal neurological deficit, Parinaud syndrome, and hydrocephalus occurred in 9%, 7%, and 3% of cases, respectively. CONCLUSIONS: SRS is a safe modality for the management of pineal region tumors. Its specific role is highly dependent on tumor histology. As such, all efforts should be made to obtain a reliable histologic diagnosis.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Iorio-Morin C, Kano H, Huang M, et al. Histology-Stratified Tumor Control and Patient Survival After Stereotactic Radiosurgery for Pineal Region Tumors: A Report From the International Gamma Knife Research Foundation. World Neurosurg. 2017. PMID: 28751141. doi:10.1016/j.wneu.2017.07.097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。